Synlogic announces fourth quarter and full year 2021 conference call and webcast

Cambridge, mass., march 10, 2022 (globe newswire) -- synlogic, inc. (nasdaq: sybx), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its proprietary approach to synthetic biology, today announced the company will release its fourth quarter and full year 2021 financial results before the market opens on thursday, march 17, 2022. the press release will be followed by a conference call at 8:30 am et, which will be open to the public via telephone and webcast. during the conference call, the company will review its financial results and provide a corporate update.
SYBX Ratings Summary
SYBX Quant Ranking